Opinion

First Wednesdays in collaboration with data from Crunchbase and Seedrs last week released their report titled ‘The European Cannabis Investment Ecosystem (ECIE), examining “the scope and scale of major, EU-wide…

The decriminalisation of psychedelic drugs is undoubtedly an important step for social justice. However, there is a much larger issue that needs to be addressed for the psychedelic movement. To…

  When otherwise polarised groups are shown to agree on some political measure, the smart politician takes note. To that end, the magic mushroom story du jour should make for…

  Michael Wakelyn-Green is a Drug Policy Campaigner, Drug & Alcohol Recovery Specialist, and South East Ambassador for the LCDPR. With Lockdown ending mid-June (fingers-crossed), it means many UK festivals…

  There is no doubt that psychedelics hold incredible healing potential to treat mental illnesses. Their ability is so great, claims circulate that they can ‘cure’ conditions, a term almost…

  Drug policy is a complex sphere to navigate for a whole host of reasons. The most important and difficult being that drug use is perceived to be a moral…

  Psychedelics are making a comeback. We’ve recently witnessed a wave of re-emerging interest and research into psychedelic drugs. This has undoubtedly been a beneficial force for breaking down stigma,…

  Our understanding of how psychoactive substances affect us has been largely based on researching their intoxicating effects. But what about the after effects? I’m talking about the comedowns, the…

  It’s been a great start to the year for social justice in cannabis reform, with the expungement of 500,000 low-level cannabis offences in the state of Illinois. This has…

  Oftentimes we are keen to distinguish between medical and recreational cannabis use. But does this distinction do more harm than good for advancing recreational reform? Many assume that this…